Company Profile
Neophore Limited
10762171•Private Limited With Share Capital
Get Full Access
09/05/2017
9 years
9
14
72110
very low risk
Company Overview
Registration, classification & business activity
Neophore Limited (10762171) is a private limited with share capital incorporated on 09/05/2017 (9 years old) and registered in cheshire, WA142DT. The company operates under SIC code 72110 - research and experimental development on biotechnology.
Neophore is creating novel small molecule immuno-oncology therapeutics. neophore's drugs target genetic mechanisms that both clinical and lab validation studies suggest will promote neoantigen creation and diversity across numerous cancers. alone or in combination with other cancer immunotherapies, ...
Financial Overview
£5.29M
£1.09M
£4.20M
£4.07M
Key Metrics
14
Employees
9
Directors
84
Shareholders
12
Patents
Board of Directors
Innovate Grants
This company received a grant of £789748.0 for A Novel Small Molecule Approach To Enhance Cancer Immunotherapy. The project started on 01/07/2017 and ended on 31/03/2020.
Import / Export
Risk Assessment
very low risk
International Score
Future Factor
excellent
Performance Rating